These results show that TORC1 inactivation counteracts the damaging effects of DS, while they also suggest that TORC1 activity may be at least partially disabled already in the stk10 strain, requiring calibration of rapamycin to avoid excessive, damaging inhibition of TORC1. This evidence concerns the gene CRTC1 and Dravet syndrome.